Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?

被引：0
|
作者：
Murphy, M. L. [1 ]
Chan, S. K. W. [1 ]
Bazley, L. [1 ]
Hayes, N. V. L. [1 ]
Gullick, W. J. [1 ]
机构：
[1] Univ Kent, Dept Biosci, Canterbury, Kent, England
来源：
BREAST CANCER RESEARCH | 2006年 / 8卷 / Suppl 2期
关键词：
Epidermal Growth Factor Receptor; Breast Cancer Patient; Human Epidermal Growth Factor Receptor; Humanize Monoclonal Antibody; Herceptin;
D O I：
10.1186/bcr1590
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [31] Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens
    Taylor, SL
    Platt-Higgins, A
    Rudland, PS
    Winstanley, JHR
    Barraclough, R
    INTERNATIONAL JOURNAL OF CANCER, 1998, 76 (04) : 459 - 463
  • [32] Adjuvant trastuzumab with docetaxel or vinorelbine for HER-2-positive breast cancer
    Ferretti, Gianluigi
    Papaldo, Paola
    Fabi, Alessandra
    Carlini, Paolo
    Felici, Alessandra
    Cognetti, Francesco
    ONCOLOGIST, 2006, 11 (07): : 853 - 854
  • [33] Prognostic significance of serum c-erbB-2 protein in breast cancer patients
    Willsher, PC
    Beaver, J
    Pinder, S
    Bell, JA
    Ellis, IO
    Blamey, RW
    Robertson, JFR
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 40 (03) : 251 - 255
  • [34] ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients
    Meenakshi, A
    Kumar, RS
    Kumar, NS
    JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2002, 23 (03): : 293 - 305
  • [35] DETERMINATION OF C-ERBB-2 ONCOPROTEIN IN SERUM OF PATIENTS WITH BREAST-CANCER
    MITZE, M
    KREIENBERG, R
    WEIKEL, W
    BECK, T
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 838 - 840
  • [36] Serum c-erbB-2 levels in monitoring of operable breast cancer patients
    Imoto, S
    Kitoh, T
    Hasebe, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (07) : 336 - 339
  • [37] HER-2-Positive Breast CancerHope Beyond Trastuzumab
    Rupert Bartsch
    Catharina Wenzel
    Christoph C. Zielinski
    Guenther G. Steger
    BioDrugs, 2007, 21 : 69 - 77
  • [38] Evaluation of Cardiotoxicity in HER-2-Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab
    Bachir, Bachir
    Anouti, Sirine
    Jaoude, Joseph Abi
    Kayali, Majd
    Tfayli, Arafat
    de Azambuja, Evandro
    Poortmans, Philip
    Zeidan, Youssef H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (01): : 135 - 142
  • [39] Amplification of c-erbB-2 gene in female breast cancer
    Zadrozny, M
    Smolarz, B
    Romanowicz-Makowska, H
    Kozlowska, E
    Kulig, A
    EXPERIMENTAL ONCOLOGY, 2002, 24 (03): : 198 - 202
  • [40] EGFR and c-erbB-2 expression in breast cancer progression
    Chong, D
    Reeves, J
    Cooke, T
    George, WD
    Mallon, E
    Ozanne, B
    Stanton, P
    BRITISH JOURNAL OF CANCER, 1998, 78 : 24 - 24
12345